Events

Below is a list of events where CELT Global Health researchers and staff are presenting CELT Global Health research, or events that CELT Global Health is endorsing.

An illustration of a bulb alight above a global heat map of amber lights. The text reads

LA-LINK

September, Online workshop

LA-LINK is our new seminar and workshop series designed to bring together researchers, developers, policymakers, funders, and implementers working across the rapidly evolving field of long-acting therapeutics.

LA-LINK context

Long-acting medicines and technologies are transforming prevention and treatment for a range of conditions that disproportionately affect people in LMICs. As the field advances, so does the need for accessible, and LA-LINK aims to be a cross-stakeholder learning space where expertise can be shared, challenges identified, and new collaborations connected.

You can find out more details about LA-LINK on our Partnership Coordination project page, but each workshop will feature:

Focused expert talks or panels
Space for Q&A and community discussion
Session summaries and materials shared afterward

The third LA-LINK workshop

We will post the full details soon.

Register

We will add registration information soon.

Whether you’re deeply embedded in long-acting research or just beginning to explore the field, you’re warmly invited to be part of this growing community via LA-LINK.

the BSNM annual conference 2026, has a picture of the UCL East building, the dates 26-28 September and text we'll highlight below.

British Society for Nanomedicine Annual Conference 2026

26-28 August 2026, UCL East, London UK

This conference has 20+ presentation slots with an emphasis on early career researchers, industry and academic taskforce meetings and workshops and discussion groups. The key topics are:

Improving the translation of nanomedicine
Improved drug deliver through targeting drug release strategies
Understanding and predicting biological interactions
Novel and emerging nanotechnologies in medicine.

Abstract submission deadline is Tuesday 30 June.

Find out more, including how to register on the BSNM 2026 event page.

A group of clinicians are talking. Text includes the event title, dates of event and abstract submission which are explained below and

27th International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs

2-3 September 2026, Montreal Canada

We're endorsing this this two-day hybrid workshop from Academic Medical Education. It gathers leading experts to discuss all aspects of the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational and existing drugs, pharmacodynamics, drug dosing in under represented populations, post-marketing surveillance, and regulatory considerations.

Abstract deadline: Friday 29 May 2026.

Find out more, including how to register and abstract information on the Workshop website.

Two scientists work in their lab. The LA-GLOBAL logo is at the top, there are event details and the tagline

LA-GLOBAL

29-30 October 2026, Liverpool UK

We're pleased to announce our brand new conference we're hosting and curating.

LA-GLOBAL's mission is to accelerate the translation of long-acting science into equitable health outcomes, particularly for communities in low- and middle-income countries where the need is greatest and access has historically lagged furthest behind.

Both registration and abstract submission are now open (abstract deadline 23.06.26, early bird tickets deadline 22.07.26). Find out more on our LA-GLOBAL conference page.

Keynote speakers

Each LA-GLOBAL theme has a keynote speaker and we're pleased to announce them:

Advances in long-acting manufacturing - Professor Ryan Donnelly from Queen's University Belfast
Frontiers in long-acting drug delivery - Professor René Holm from the University of Southern Denmark
Maternal and paediatric health - Professor Elaine Abrams from Columbia University
Biological performance of long-acting therapeutics - Dr Alison Cave from Medicines and Healthcare products Regulatory Agency (MHRA)
Preclinical pharmacology and pharmacometrics - Professor Pieter Annaert from KU Leuven.

CELT Global Health's Community of Practice for long-acting therapeutics for maternal and paediatric health

Community of Practice context

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this Community of Practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
Synthesise evidence-based perspectives on best practices for long-acting therapeutics
Disseminate outputs from the community of practice for uptake by the wider community.

The next Community of Practice webinar

Will be announced soon, please check back or follow our social media for updates.

To join the Community of Practice and attend this meeting, please fill in this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. New members are welcome to join the Community of Practice at any point.

Previous events

26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025

The key takeaways from this workshop can be found on the event's enduring materials page and the abstracts are available in the British Journal of Clinical Pharmacology.

CELT Global Health's Community of Practice meetings

January meeting - Launch

A recording of the first session where the key objectives were set can be found on our YouTube channel.

March meeting - Dynamic paediatric and maternal physiology in long-acting therapeutics development

A recording of the first webinar addressing the dynamic physiology of both paediatric and maternal patients in long-acting therapeutics development is available on CELT Global Health's YouTube channel.

July meeting - First in person

We have separated the recordings that are available for each session. These were maternal health, paediatric health and global health.

October meeting - Considerations for long-acting injectable microsuspension development: Anti-malarial therapy lessons

A video of the October session from Laxman Cherkupally from Medicines for Malaria Venture is available on our YouTube channel.

Advances in Long-acting Therapeutics meeting

A recording of CELT Global Health's Dr Catherine Unsworth's 14 minute talk is available on CELT Global Health's YouTube channel.

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks on LEAP's Bioequivalence workshop recordings page.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch a recording of CELT Global Health co-Director Prof. Andrew Owen's presentation.

Find all the recordings from the workshop on LEAP's long-acting tuberculosis recordings page.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks on the Clinical Pharmacology and Antiretrovirals course page

LEAP | Investigator Meeting & Annual Workshop 2023 - 18 February 2023

Watch a recording of an update from LONGEVITY delivered by Professor Andrew Owen available on LEAP's investigator meeting and annual workshop 2023 page.

Access the full workshop on the event page.